1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Antihistamines Market
2.2. Global Antihistamines Market, By Antihistamines, 2023 (US$ Million)
2.3. Global Antihistamines Market, By Application, 2023 (US$ Million)
2.4. Global Antihistamines Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Antihistamines Market: Competitive Analysis
3.1. Market Positioning of Key Antihistamines Market Vendors
3.2. Strategies Adopted by Antihistamines Market Vendors
3.3. Key Industry Strategies
4. Antihistamines Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Antihistamines Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. First Generation Antihistamines
5.3.1.1. Alimemazine
5.3.1.2. Chlorphenamine
5.3.1.3. Clemastine
5.3.1.4. Cyproheptadine
5.3.1.5. Hydroxyzine
5.3.1.6. Ketotifen
5.3.1.7. Promethazine
5.3.1.8. Others(Carbinoxamine, Dimenhydrinate, and others)
5.3.2. Second Generation Antihistamines
5.3.2.1. Acrivastine
5.3.2.2. Cetirizine
5.3.2.3. Desloratadine
5.3.2.4. Fexofenadine
5.3.2.5. Levocetirizine
5.3.2.6. Loratadine
5.3.3. Pipeline Analysis: Antihistamines Market
5.3.3.1. Phase III (Forecast till 2026)
5.3.3.2. Phase II (Tabular Representation)

6. Antihistamines Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Allergic Rhinitis
6.3.2. Conjunctivitis
6.3.3. Urticaria
6.3.4. Atopic Dermatitis
6.3.5. Anaphylaxis
6.3.6. Others (Angioedema, Pruritus, and others)


7. North America Antihistamines Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
7.3. Antihistamines Market: By Application, 2022-2032, USD (Million)
7.4.Antihistamines Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
7.4.1.1.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
7.4.1.2.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
7.4.1.3.2. Antihistamines Market: By Application, 2022-2032, USD (Million)

8. UK and European Union Antihistamines Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
8.3. Antihistamines Market: By Application, 2022-2032, USD (Million)
8.4.Antihistamines Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
8.4.1.1.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
8.4.1.2.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
8.4.1.3.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
8.4.1.4.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
8.4.1.5.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
8.4.1.6.2. Antihistamines Market: By Application, 2022-2032, USD (Million)

9. Asia Pacific Antihistamines Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
9.3. Antihistamines Market: By Application, 2022-2032, USD (Million)
9.4.Antihistamines Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
9.4.1.1.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
9.4.1.2.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
9.4.1.3.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
9.4.1.4.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
9.4.1.5.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
9.4.1.6.2. Antihistamines Market: By Application, 2022-2032, USD (Million)

10. Latin America Antihistamines Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
10.3. Antihistamines Market: By Application, 2022-2032, USD (Million)
10.4.Antihistamines Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
10.4.1.1.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
10.4.1.2.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
10.4.1.3.2. Antihistamines Market: By Application, 2022-2032, USD (Million)

11. Middle East and Africa Antihistamines Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
11.3. Antihistamines Market: By Application, 2022-2032, USD (Million)
11.4.Antihistamines Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
11.4.1.1.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
11.4.1.2.2. Antihistamines Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Antihistamines Market: By Antihistamines, 2022-2032, USD (Million)
11.4.1.3.2. Antihistamines Market: By Application, 2022-2032, USD (Million)

12. Company Profile
12.1. Bayer AG
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Almirall S.A.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Johnson & Johnson
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. AstraZeneca plc
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Novartis AG
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Pfizer, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Sanofi SA
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Boehringer Ingelheim GmbH
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Merck & Co., Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Akorn, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Teva Pharmaceutical Industries Ltd.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Celgene Corporation
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. F. Hoffman-La Roche
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives